FOXP3 and immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome: Applications include diseases of Treg deficiency, such as IPEX syndrome.[201] CRISPR‐Cas9 gene editing has recently been used to correct FOXP3 mutations in patient‐derived cells.